Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Application of the composition containing nicotinamide mononucleotide in anti-aging medicine/health product

A single nucleotide and composition technology, which is applied in the direction of medical preparations, applications, and drug combinations containing active ingredients, can solve problems such as difficult to take into account the anti-aging effect and product quality stability, and achieve good anti-aging effect and stable structure , the effect of not easy to deteriorate and damage

Active Publication Date: 2021-06-25
HOBOOMLIFE BIO TECH SHENZHEN CO LTD
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] In view of this, the present invention provides the application of the composition containing nicotinamide mononucleotide in anti-aging medicines / health care products, which is used to solve the problems in the prior art that anti-aging products have a good anti-aging effect and are harmful to the human body. Technical defects without hazards and stable product quality

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of the composition containing nicotinamide mononucleotide in anti-aging medicine/health product
  • Application of the composition containing nicotinamide mononucleotide in anti-aging medicine/health product
  • Application of the composition containing nicotinamide mononucleotide in anti-aging medicine/health product

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] This embodiment is a specific embodiment for preparing product 1.

[0043] Niacinamide mononucleotide, evodiamine, resveratrol, sumac, butaein, icariin and honokiol were dried separately, passed through a 60-80 mesh sieve, and mixed uniformly to obtain the first product;

[0044] After the auxiliary materials are dried, mix them evenly, and pass through a 60-80 mesh sieve to obtain the second product; in this embodiment, the auxiliary materials are mannitol.

[0045] After the first product and the second product are dissolved in water, stir for the first time at 25-40°C, heat up after stirring evenly, then stir for the second time at 50°C, and after stirring for 1 hour, the preparation is tablet product 1; In the examples, the formulation process used is a conventional formulation process well known to those skilled in the art, and will not be repeated here.

[0046] In this example, in the first product, the dosage of each raw material is: 10g of nicotinamide mononuc...

Embodiment 2

[0048] This embodiment is a specific embodiment for preparing product 2.

[0049] Niacinamide mononucleotide, evodiamine, resveratrol, sumac, butaein, icariin and honokiol were dried separately, passed through a 60-80 mesh sieve, and mixed uniformly to obtain the first product;

[0050] After the auxiliary materials are dried, mix them evenly, and pass through a 60-80 mesh sieve to obtain the second product; in this embodiment, the auxiliary materials are microcrystalline cellulose.

[0051] After the first product and the second product are dissolved in water, stir for the first time at 25-40°C, heat up after stirring evenly, then stir for the second time at 50°C, and after stirring for 1 hour, the product 2 is obtained as a pill; this implementation In the example, the formulation process used is a conventional formulation process well known to those skilled in the art, and will not be repeated here.

[0052] In this example, in the first product, the dosage of each raw mat...

Embodiment 3

[0054] This embodiment is a specific embodiment for preparing product 3.

[0055] Niacinamide mononucleotide, evodiamine, resveratrol, sumac, butaein, icariin and honokiol were dried separately, passed through a 60-80 mesh sieve, and mixed uniformly to obtain the first product;

[0056] After the auxiliary materials are dried, mix them evenly, and pass through a 60-80 mesh sieve to obtain the second product; in this embodiment, the auxiliary materials are magnesium stearate.

[0057] After the first product and the second product are dissolved in water, stir for the first time at 25-40°C, heat up after stirring evenly, then stir for the second time at 50°C, and after stirring for 1 hour, the preparation is granule product 3; In the examples, the formulation process used is a conventional formulation process well known to those skilled in the art, and will not be repeated here.

[0058] In this example, in the first product, the dosage of each raw material is: 2 g of nicotinam...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle size (mesh)aaaaaaaaaa
Login to View More

Abstract

The invention belongs to the research and development field of medicines and health-care products, and particularly relates to the application of a nicotinamide mononucleotide-containing composition in anti-aging medicines / health-care products. The present invention provides a composition, the present invention also provides a preparation method of the above-mentioned composition, and the present invention also provides a product obtained from the above-mentioned composition or the above-mentioned preparation method in anti-aging medicines and / or health care products Applications. In the present invention, NMN can play the role of activating the body's energy metabolism and improving the body's oxidative stress response, and at the same time, with the synergistic effect of the other components, it has a good anti-aging effect; It is stable, and is not prone to deterioration and damage after the corresponding product is prepared. At the same time, each component is safe and basically has no adverse reaction to the human body; it solves the problem that in the prior art, anti-aging products are difficult to take into account good anti-aging effects, no harm to the human body and Technical defects with stable product quality.

Description

technical field [0001] The invention belongs to the field of research and development of medicines and health products, and in particular relates to the application of a composition containing nicotinamide mononucleotide in anti-aging medicines / health products. Background technique [0002] With the continuous improvement of people's living standards, people's desire to pursue health and longevity is becoming stronger and stronger. However, aging is an inevitable law in any life process and a biological law that does not depend on human will. However, it is possible to delay the aging speed and make people's lifespan reach the maximum lifespan endowed by nature. So far, there have been hundreds of theories and hypotheses about the mechanism of aging, such as free radical theory, immune function degeneration theory, neuroendocrine theory, protein synthesis error accumulation theory, etc., as well as gene regulation based on molecular and gene levels in recent years. theory, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/706A61K31/519A61K31/352A61K31/7048A61K31/05A61K31/12A61P39/06A23L33/10
CPCA23V2002/00A61K31/05A61K31/12A61K31/352A61K31/519A61K31/7048A61K31/706A23L33/10A61P39/06A61K2300/00A23V2200/302A61P39/00
Inventor 陈建生段志刚
Owner HOBOOMLIFE BIO TECH SHENZHEN CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com